home / stock / cdmop / cdmop news

CDMOP News and Press, Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock From 06/27/19

Stock Information
Company Name: Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock
Stock Symbol: CDMOP
Market: NASDAQ
Website: avidbio.com
Menu
CDMOP CDMOP Quote CDMOP Short CDMOP News CDMOP Articles CDMOP Message Board
Get CDMOP Alerts

News, Short Squeeze, Breakout and More Instantly...
CDMOP - Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments

  -- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146%  Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- -- Increasing Demand from Customers Expected to Drive Continued R...
CDMOP - Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2019 After Market Close on June 27, 2019

TUSTIN, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology an...

CDMOP - Avid Bioservices to Participate at BIO International Convention 2019

-- Company to Provide Insight on Key CDMO Industry Topics through Podium Presentation, Panel Discussion and Executive Interview as Part of Convention’s BioProcess  International Theater -- -- Corporate Booth to Highlight Company’s CDMO Service Offerings and State-of...

CDMOP - Avid Bioservices Reaffirms Fiscal 2019 Guidance and Announces Upcoming Conference Participation

TUSTIN, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotech...
CDMOP - Avid Bioservices Names Richard B. Hancock as Interim President and Chief Executive Officer

TUSTIN, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotech...

CDMOP - Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2019 and Recent Developments

-- Achieved Revenue of $13.8 Million, an Increase of 102% Compared to Prior Year Quarter -- -- Signed Project Expansion Orders with Existing Customers Representing $23.8 Million -- -- Completed Process Validation Campaign for Future Commercial Production with Other Validations ...

CDMOP - Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

TUSTIN, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology a...
CDMOP - Avid Bioservices To Report Financial Results For Third Quarter Of Fiscal Year 2019 After Market Close On March 11, 2019

TUSTIN, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology a...

Previous 10 Next 10